Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Accendra Health (ACH) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Accendra Health (ACH) over the last 17 years, with Q3 2025 value amounting to $4.4 billion.

  • Accendra Health's Total Non-Current Liabilities rose 714.81% to $4.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 billion, marking a year-over-year increase of 714.81%. This contributed to the annual value of $4.0 billion for FY2024, which is 121.89% down from last year.
  • Per Accendra Health's latest filing, its Total Non-Current Liabilities stood at $4.4 billion for Q3 2025, which was up 714.81% from $4.4 billion recorded in Q2 2025.
  • Over the past 5 years, Accendra Health's Total Non-Current Liabilities peaked at $4.6 billion during Q1 2022, and registered a low of $2.5 billion during Q4 2021.
  • In the last 5 years, Accendra Health's Total Non-Current Liabilities had a median value of $4.2 billion in 2025 and averaged $3.9 billion.
  • In the last 5 years, Accendra Health's Total Non-Current Liabilities plummeted by 2151.92% in 2021 and then skyrocketed by 8481.13% in 2022.
  • Over the past 5 years, Accendra Health's Total Non-Current Liabilities (Quarter) stood at $2.5 billion in 2021, then soared by 73.79% to $4.3 billion in 2022, then dropped by 6.45% to $4.0 billion in 2023, then fell by 1.22% to $4.0 billion in 2024, then increased by 9.64% to $4.4 billion in 2025.
  • Its last three reported values are $4.4 billion in Q3 2025, $4.4 billion for Q2 2025, and $4.2 billion during Q1 2025.